Pharma Reviews: GIPC Index And US Special 301 Report: (Ir)relevance For India

It may be advantageous to multinational pharmaceutical companies, but it is at the cost of the public health in developing economies. Therefore, being a ...
Read more: GIPC Index And US Special 301 Report: (Ir)relevance For India